Buy Cybergy Holdings

In: Tips

20 Apr 2015

Hi Everybody,

Our alert for Monday is:
Cybergy Holdings Inc.
Ticker symbol: CYBG
Last price: $1.79

Cybergy Holdings Inc. provides cyber security, smart grid technologies and renewable energy solutions to both government and private industry clients.

CYBG Fast Facts
• Headquartered in Englewood, Colorado
• Approximately 100 employees
• 3 divisions
• 2014 revenue $32 million

5 reasons investors are excited about CYBG
1. CYBG posts 140% increase in contracts between 2013 and 2014.
2. CYBG lands $500 million 10 year contract with U.S. Department of Health and Human Services.
3. CYBG will serve as a key partner to Allegheny Science & Technology Corp. (AST) on an $85 million 3 year contract.
4. CYBG Labs expects to release its cyber security platform SmartFile in 2015.
5. CYBG announced it plans to uplist to NASDAQ. (Nasdaq requires a $4 price to qualify)

Make sure you’re ready to book your profits with CYBG!

Free Stock TipsAs always, do your own research, don’t chase gaps, use limit orders to enter positions, always use stop loss orders to protect your position, and take profits when you are in a position to do so.

Good Trading

Hi Everybody,

Winners are popping up left and right, so we found an opportunity that could bring you some profits on Thursday morning!

It’s a stock we’ve covered before that has made traders big money, and looks set to do just that again.

The exciting thing is, there was just a mini-documentary shot at their $20 million tea operation in South Africa.

This is huge because OTC investors are generally skeptical on the operations of these companies, so this video should quell the concerns many investors normally have and could attract some big long term holders, which is great for the stock price!

Our alert for Thursday is:

Plandai Biotechnology

Ticker symbol: PLPL
Last price: $ 0.23

PLPL and its operations at the Senteeko tea estate in South Africa are the subject of a newly released video.

Watch the video here:

In the documentary, viewers get a look inside the gates of the Senteeko tea estate and see for themselves the beauty that makes up the property’s 8,000 acres. The video also highlights the many fields of tea that produce the raw material that Plandaí uses to make its highly bioavailable green tea extract, Phytofare® Catechin Complex.

PLPL’s video also visits North West University’s Potchefstroom Campus and learn first-hand, from the scientists there who put the company’s green tea extract through human clinical trials, just what bioavailability is and why getting the product into the bloodstream and keeping it there is so important to end users of Plandaí’s product or of any nutraceutical product for that matter.

The Head of the University’s Preclinical Drug Development Platform, Prof. Anne Grobler, explains PLPL’s incredible clinical trial results, and we learn more about the Pheroid technology that the company will employ to deliver its extracts deeper into the body on the cellular level.

While at Senteeko viewers get to see the company’s 30,000 square foot production facility and watch the staff at the factory turn tea leaves into a vibrant, rich emerald green colored green tea extract. In the video, both the company’s CEO and the V.P. of Sales and Marketing discuss Senteeko’s early days, the tea estate today, the production process, Plandaí’s sales and marketing efforts and its future plans with other extracts.

This video gives investors and traders a front row seat to see the potential in PLPL.

Make sure you’re ready to book your profits with PLPL!

Free Stock TipsAs always, do your own research, don’t chase gaps, use limit orders to enter positions, always use stop loss orders to protect your position, and take profits when you are in a position to do so.

Good Trading

Buy SPYR

In: Tips

9 Apr 2015

Hi Everybody,

We’ve been having a great week so far. Today’s alert may be the best one yet!

This company is starting to hit some major radars. It’s seeing a lot of interest because of its potential in the fast growing digital advertising and mobile applications market.

The company also has over $6 million in the bank so it’s poised for expansion.

Our alert for Thursday is:
SPYR, Inc.
Ticker symbol: SPYR
Last price: $0.65

SPYR is a holding company, that through its wholly-owned subsidiary, Franklin Networks, is engaged in digital publishing and advertising operations.

SPYR currently owns and operates nine websites focused on topics including, food, travel, fitness, nutrition, fashion and parenting.

By creating valuable and sharable content on these sites, SPYR will be able to leverage the traffic and synergies between the sites to offer advertisers package deals on secondary markets.

In case you haven’t noticed this whole “internet advertising” thing is kind of a big deal.

Online ad sales continue to register double-digit percentage growth year over year. In 2013, online ad sales rose 17 percent to $42.8 billion up from $26 billion in 2010 and only $9.6 billion in 2004. In the U.S., the total digital advertising spend alone will rise to more than $52 billion in 2015 and will climb to more than $61 billion by 2017. It is numbers like this that explain why the transition by SPYR into the digital publishing space makes a whole lot of sense.

Oh, and they’ve also entered into the mobile app space with the creation of SPYR APPS LLC.?

The timing is perfect to enter the multi-billion dollar apps and games industry. A recent article highlighting the apps industry found that by 2017, it’s expected that over 268 billion app downloads will generate $77 billion worth of revenue. The article points out that in 2015 alone, 1 billion smartphones will be purchased. The popularity of the smartphone isn’t slowing down, and with it the popularity of downloading apps is growing exponentially.

With numbers like that it’s clear to see why even the digital games industry has gone mobile. The mobile apps industry is expected to grow 16.5 percent in 2015 with gaming apps accounting for over 30 percent of the U.S. mobile content market in 2015.

Not to mention that the company is cash positive, with over $6 million in the bank! Meaning they already have capital in place which is more than most OTC companies can say.

With all this going on it’s not hard to see why investors are flocking to SPYR.

Make sure you’re ready to book your profits with SPYR!

Free Stock TipsAs always, do your own research, don’t chase gaps, use limit orders to enter positions, always use stop loss orders to protect your position, and take profits when you are in a position to do so.

Good Trading

Buy FONU2

In: Tips

8 Apr 2015

Hi Everybody,

Hope you had a good day yesterday, our drone call ran up 33% at one point.

Congratulations to everyone who booked profits!

So let’s keep it moving, to a penny with some big names involved, and looking like a major breakout is brewing.

Our alert for Wednesday is:

FONU2, Inc.
Ticker symbol: FONU
Last price: $0.09

FONU is a film studio, production and social commerce company actively developing a 1,560 acre film studio complex, “Studioplex” in Effingham County, Georgia.

Why Georgia?
• Georgia is #1 in growth nationwide for film in production ahead of both California and New York.
• Demand in Georgia far outweighs supply.
• Georgia currently has an inventory shortage estimated at over 20 soundstages to accommodate the entertainment business needs.
• Record government support including grants, rebates and tax incentives enhances profitability.
• In 2014 alone, Georgia feature films and television productions generated an economic impact of $5.1 billion.
• Qualifying productions receive up to a 30% tax credit.

Hollywood Elite Onboard
In addition to building the Studioplex, the company has also acquired the worldwide distribution rights to Nick Cassavete’s Yellow. Cassavete’s wrote and directed Yellow. He has also directed and wrote for many other notable films such as The Other Woman, The Notebook, John Q, and Blow to name a few.

FONU is also producing a film being directed by the legendary Penny Marshall, who directed According to Jim, A League of Their Own, Big,Jumpin’ Jack Flash, and Laverne & Shirley.

The Hollywood experience doesn’t end there as FONU recently appointed new COO Alice P. Neuhauser whose resume includes financing some of the largest independently financed pictures including Terminator 2, Cliffhanger, Basic Instinct and Total Recall.

Investment Highlights
• Largest studio project in America.
• Cost savings versus competing studios.
• Management team track record includes both the successful creation and construction of a leading production studio as well as producing over 200 movies, which have generated in excess of $3 billion in box office receipts.

FONU looks like it could have a huge week heading into their presentation at the Growth Capital Expo next week. With that in mind traders are snatching up shares, and this could be a major winner for anyone involved.

Make sure you’re ready to book your profits with FONU!

Free Stock TipsAs always, do your own research, don’t chase gaps, use limit orders to enter positions, always use stop loss orders to protect your position, and take profits when you are in a position to do so.

Good Trading

Hi Everybody,

Commercial drones are hot!

Drones are poised to have a huge impact on the US economy, according to the world’s largest unmanned systems industry organization.  The report released by the Association for Unmanned Vehicle Systems International (AUVSI) forecasts the total domestic impact to reach more than $82 billion.

Recently, a commercial drone stock VMRI, ran almost 200% from 2 bucks to almost 6 dollars!

So when we saw this news after market we knew we had to scramble and get a report to you ASAP!

The company we’re alerting you to, just released news after the bell that they acquired 100% of the licensing rights for manufacturing and distribution of North American Drones Enterprise Inc.’s (NAD) branded line of drone product!

Our alert for Tuesday is:
Golden Star Enterprises, Ltd.
Ticker symbol: GSPT
Last price: $0.09

NAD is in the business of producing and marketing drones to a wide range of potential users for commercial and recreational use.  Drones, most commonly associated with military applications are increasingly developing civil applications.

Drone services include aerial surveying, aerial video and photography, search and rescue operations, inspecting power lines and pipelines, counting wildlife, delivery of supplies (particularly to remote areas), forest fire detection, surveillance, and much more.  A large number of tasks performed from the ground today that are either personnel intensive, infrastructure intensive, or time intensive, can be more easily accomplished through the use of drones.

GSPT’s focus is to sell drones that make it easy for the everyday consumer to use and allow businesses to provide services new to their industry.  The core business can be divided into two main areas:
1. The highly customized sales of drones in the “Mini”, the “Prosumer” and “commercial use” market segments; and,
2. The leasing of purpose built drones to assist the private sector in specific lines of work.

GSPT currently has three different drones in their brand and they are, The X Factor (18.5×18.5x2cm), Kasper (35x35x10cm) and I-Sky (80x40x42cm).  What differentiates NAD from its competitors is that its drones are sold at a lower price point, and its drones can be operated by novices and experts alike.

GSPT through NAD has an exclusive co-branding, distribution agreement in place with one of the top drone makers in the world (manufacturer of “Ghost” drones) to sell co-branded drones throughout North America.

As we said, the drone market is going to be huge and investors are taking a bite at every opportunity they have to get into this market.  GSPT may be the best option yet, and at this price point could bring investors back value very quickly.

Make sure you’re ready to book your profits with GSPT!

Free Stock TipsAs always, do your own research, don’t chase gaps, use limit orders to enter positions, always use stop loss orders to protect your position, and take profits when you are in a position to do so.

Good Trading

Buy PharmaCyte Biotech

In: Tips

25 Mar 2015

Hi Everybody,

Everyday there’s a new biotech running, creating profit opportunities for savvy traders.

With this in mind we found a nice looking biotech, that has received FDA orphan drug designation for their pancreatic cancer treatment. They are in phase 2b of clinical trials which are expected to commence this year.

That’s not all, this pancreatic treatment is based on the company’s cellulose-based live cell encapsulation technology known as Cell-in-a-Box(R) which may also be useful in treatment for other forms of cancer as well as diabetes.

The fact is this company has a real shot at making some waves as larger investors are more willing to take chances on little known biotechs due to the current market condition.

Our alert for Wednesday is:
PharmaCyte Biotech, Inc.
Ticker symbol: PMCB
Last price: $0.10

PMCB is a clinical stage biotechnology company focused on developing and preparing to commercialize treatments for cancer and diabetes based upon a proprietary cellulose-based live cell encapsulation technology known as Cell-in-a-Box(R).

PMCB’s patented Cell-in-a-Box treatment, has earned FDA ‘orphan drug designation’, for the treatment of pancreatic cancer. They will be executing Phase 2b of their clinical trials vs. a treatment using Eli Lilly’s Gemzar and Celgene’s Abraxane®.

Celgene is a billion dollar market cap company, and Eli Lilly is even bigger…if PMCB’s trials are successful this could end up as a wild ride for early investors.

But even before any of that happens, the sheer potential of this story as it makes its rounds could make for some major price swings.

The smallcap biotech sector is leading the market, and PMCB is a beautiful opportunity at capitalizing on this trend.

Make sure you’re ready to book your profits with PMCB!

Free Stock TipsAs always, do your own research, don’t chase gaps, use limit orders to enter positions, always use stop loss orders to protect your position, and take profits when you are in a position to do so.

Good Trading

Hi Everybody,

The future looks bright for our alert for Wednesday. If you take a look at their recent numbers you will see why investors will be trampling over each other to buy shares in this up and coming solar company.

This company’s numbers tell the story:
• 19 consecutive quarters of improvement.
• 3 profitable quarters in a row.
• $5.4 million in sales for the first 9 months of 2014 (up almost 100% from 2013).
• $971,594 in profits for the first 9 months of 2014.

Our alert for Wednesday is:
Atlantic Wind & Solar, Inc.
Ticker symbol: AWSL
Last price: $0.34

AWSL is renewable energy asset developer, with emphasis on photovoltaic solar (PV) and wind energy.

AWSL’s portfolio is diversified across 22 municipalities in Canada and 5 regions in Central and South America including, Ecuador and Peru.

The growth of the global renewable energy industry has soared over the past decade yet it is still in its infancy.

AWSL is based in Canada which means big opportunities. Canada is a world leader in the production and use of energy from renewable resources. As a matter of fact, wind and solar photovoltaic energy are the fastest growing sources of electricity currently providing about 16.9% of the country’s total primary energy supply.

Recent News:
• Atlantic Wind & Solar Supplies More Power to the Ontario Power Authority.
• AWSL announced the addition of another utility scale solar plant in Ontario, Canada now powering the grid. The formal receipt of a notice of Commercial Operation (COD) from the Ontario Power Authority (OPA) marks the final step in the construction and connection of this solar plant.
• The solar power plant was developed by its Canadian subsidiary Atlantic Solar Inc.
• The photovoltaic plant consists of a 111.585 KW AC / 132.345 KW DC fixed array of 255W poly-crystalline modules. The power will be sold to the Ontario Power Authority for 20 years at a rate of $0.713/kWh.

Conclusion:
• AWSL is clearly a well run company and has the numbers to prove it.
• AWSL continues to sign agreements that will provide long term cash flow to the company and their portfolio continues to grow.
• There should be new numbers out soon, and because AWSL has improved 19 quarters in a row, it is pretty safe to say, they should be strong.
• With more and more investors learning about AWSL over the next few days this sleepy little stock is sure to get moving creating HUGE profit opportunities for those that get on board.

Make sure you’re ready to book your profits with AWSL!

Free Stock TipsAs always, do your own research, don’t chase gaps, use limit orders to enter positions, always use stop loss orders to protect your position, and take profits when you are in a position to do so.

Good Trading

Buy NHale – Again!

In: Tips

5 Mar 2015

Hi Everybody,

We hope you managed to get on to yesterdays alert. VTEQD opened at .033 then traded to a high of .075 for a 127% price gain.

Let’s move on to another opportunity we’ve been following, it looks positioned for its next move.

Remember NHLE our pick from last week? That stock traded up 50% in just 2 days.

Well, NHLE has come back down to its major support area and should bounce, setting up a sweet trade.

If you missed last weeks trade, here is another opportunity to catch these easy gains!

If you missed last week’s alert, take a look at it here: http://www.stips.com/share-stock-tips/buy-nhale-2/

Highlights
• This company is a medical marijuana company.
• They are actively seeking acquisitions.

Our alert for Thursday is:
NHale, Inc.
Ticker symbol: NHLE
Last price: $0.112

NHLE acquires companies within the medical and recreational cannabis market.

NHLE announced last week that they project revenues exceeding $30 million in 2015. Those numbers should really excite any trader learning about this opportunity.

Make sure you’re ready to book your profits with NHLE!

Free Stock TipsAs always, do your own research, don’t chase gaps, use limit orders to enter positions, always use stop loss orders to protect your position, and take profits when you are in a position to do so.

Good Trading

Buy VeriTeQ

In: Tips

4 Mar 2015

Hi Everybody,

Our alert for Wednesday looks amazing. We think we found a real gem here, the stock appears to be extremely undervalued based on recent news and traders taking positions at these levels will see tremendous upside.

Highlights:
• This company is a medical device company with FDA approved products.
• The US government passed legislation that should drive sales.
• This company is a potential takeover candidate.

Our alert for Wednesday is:
VeriTeQ Corporation
Ticker symbol: VTEQD
Last price: $0.03

VTEQD develops innovative, proprietary RFID technologies for implantable medical device identification, and dosimeter technologies for use in radiation therapy treatment.

VTEQD has proprietary technology, including over 100 patents, patents pending, patent licenses, and U.S. Food and Drug Administration cleared and CE marked products.

VTEQD has two principal business lines:
1. Unique Device Identification (UDI) for medical devices
2. Radiation dosimeters and other medical sensor applications.

What’s most interesting is their UDI technology. Branded as Q Inside Safety Technology, these little RFID chips VTEQD produces are placed in medical products such as breast implants.

One major issue this helps resolve is when there is a recall. Without the RFID tech, when there is a recall on a certain line of implants there’s no real way of knowing if someone’s implant should be recalled. With VTEQD’s UDI technology this will no longer be an issue.

Not only does it solve this problem, this kind of UDI technology is now being mandated by the FDA for reusable devices such as implant ‘sizers’.

In September 2013 FDA issued a Final Rule (“Rule”) which will require most medical devices sold in the U.S. to carry a UDI.

Now here’s where it gets interesting…

VeriTeQ Corporation executes term sheet for exclusive license of its Q Inside Safety Technology for the breast implant market with a $1.75 million up front payment.

VTEQD’s market cap is 42K. Can you say ‘undervalued’?

Not to mention, 80% of the breast implant market is controlled by Mentor and Allergen. Given the FDA requirements, and the cost of developing a technology like VTEQD’s, it would stand to reason that these two giants may take a long look at VTEQD as a possible acquisition.

All of these factors along with the fact the stock is only 3 cents a share make VTEQD a very intriguing opportunity. As more investors learn about this story the rush could create some huge price appreciation relatively quickly.

Make sure you’re ready to book your profits with VTEQD.

Free Stock TipsAs always, do your own research, don’t chase gaps, use limit orders to enter positions, always use stop loss orders to protect your position, and take profits when you are in a position to do so.

Good Trading

Buy NHale

In: Tips

24 Feb 2015

Hi Everybody,

Monday’s alert gained 33%, and our alert for Tuesday has the potential for big gains too, so let’s get right to it.

Highlights:
• This company is a medical marijuana company.
• They are actively seeking acquisitions.

Our alert for Tuesday is:
NHale, Inc.
Ticker symbol: NHLE
Last price: 11.8 cents

NHLE acquires companies within the medical and recreational cannabis market.

NHLE projects revenues exceeding $30 million in 2015! Those numbers should really excite any new trader learning about this opportunity.

NHLE CEO Lance Williams has 12 years experience in indoor agriculture and is referred to as a “Master Grower”, so this isn’t just some company trying to ride the cannabis wave. NHLE brings expertise to the market which should help them rise above the pack.

Toronto based investment group, Four Twenty Investments, certainly believes NHLE has explosive potential. They just committed 10 million dollars to NHLE to make more acquisitions.

NHLE is in the process of evaluating possible acquisitions.

You know what that means? Even more potential press releases that could send this stock flying.

With this big news, NHLE is sitting pretty and traders are on the edge of their seats, which means we may have a serious jump in liquidity and volatility this week.

Make sure you’re ready to book your profits with NHLE!

Free Stock TipsAs always, do your own research, don’t chase gaps, use limit orders to enter positions, always use stop loss orders to protect your position, and take profits when you are in a position to do so.

Good Trading


Categories

Thanks to our sponsors